Thompson Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.3M | Buy |
469,287
+5,116
| +1% | +$134K | 1.3% | 22 |
|
|
2026
Q1 | $13M | Buy |
464,171
+716
| +0.2% | +$19.1K | 1.69% | 8 |
|
|
2025
Q4 | $11.5M | Buy |
463,455
+35,325
| +8% | +$891K | 1.45% | 16 |
|
|
2025
Q3 | $10.9M | Buy |
428,130
+12,134
| +3% | +$299K | 1.46% | 17 |
|
|
2025
Q2 | $10.1M | Buy |
415,996
+5,151
| +1% | +$120K | 1.42% | 16 |
|
|
2025
Q1 | $10.4M | Buy |
410,845
+7,381
| +2% | +$193K | 1.56% | 13 |
|
|
2024
Q4 | $10.7M | Buy |
403,464
+22,179
| +6% | +$602K | 1.54% | 13 |
|
|
2024
Q3 | $11M | Buy |
381,285
+5,357
| +1% | +$156K | 1.58% | 13 |
|
|
2024
Q2 | $10.5M | Buy |
375,928
+7,703
| +2% | +$212K | 1.62% | 11 |
|
|
2024
Q1 | $10.2M | Buy |
368,225
+12,651
| +4% | +$351K | 1.55% | 14 |
|
|
2023
Q4 | $10.2M | Buy |
355,574
+206,174
| +138% | +$6.23M | 1.65% | 11 |
|
|
2023
Q3 | $4.96M | Buy |
149,400
+5,217
| +4% | +$184K | 0.88% | 44 |
|
|
2023
Q2 | $5.29M | Buy |
144,183
+11,577
| +9% | +$451K | 0.86% | 43 |
|
|
2023
Q1 | $5.41M | Buy |
132,606
+64,440
| +95% | +$2.78M | 0.92% | 42 |
|
|
2022
Q4 | $3.49M | Hold |
68,166
| – | – | 0.64% | 60 |
|
|
2022
Q3 | $2.98M | Sell |
68,166
-3,468
| -5% | -$169K | 0.58% | 66 |
|
|
2022
Q2 | $3.76M | Sell |
71,634
-1,100
| -2% | -$56.1K | 0.65% | 59 |
|
|
2022
Q1 | $3.77M | Sell |
72,734
-430
| -0.6% | -$22.3K | 0.55% | 64 |
|
|
2021
Q4 | $4.32M | Sell |
73,164
-28,525
| -28% | -$1.41M | 0.61% | 63 |
|
|
2021
Q3 | $4.37M | Sell |
101,689
-345
| -0.3% | -$15.3K | 0.65% | 57 |
|
|
2021
Q2 | $4M | Buy |
102,034
+8,550
| +9% | +$332K | 0.58% | 64 |
|
|
2021
Q1 | $3.39M | Buy |
93,484
+89
| +0.1% | +$3.16K | 0.51% | 74 |
|
|
2020
Q4 | $3.44M | Buy |
93,395
+19,805
| +27% | +$726K | 0.58% | 67 |
|
|
2020
Q3 | $2.56M | Buy |
73,590
+354
| +0.5% | +$12.4K | 0.48% | 73 |
|
|
2020
Q2 | $2.27M | Sell |
73,236
-2,635
| -3% | -$89.5K | 0.44% | 76 |
|
|
2020
Q1 | $2.35M | Hold |
75,871
| – | – | 0.52% | 65 |
|
|
2019
Q4 | $2.82M | Buy |
75,871
+2,375
| +3% | +$84.6K | 0.46% | 76 |
|
|
2019
Q3 | $2.5M | Buy |
73,496
+782
| +1% | +$28.4K | 0.49% | 76 |
|
|
2019
Q2 | $2.99M | Buy |
72,714
+8,432
| +13% | +$335K | 0.58% | 71 |
|
|
2019
Q1 | $2.59M | Buy |
64,282
+181
| +0.3% | +$7.25K | 0.5% | 75 |
|
|
2018
Q4 | $2.65M | Sell |
64,101
-17,165
| -21% | -$713K | 0.62% | 65 |
|
|
2018
Q3 | $3.4M | Sell |
81,266
-5,254
| -6% | -$202K | 0.61% | 73 |
|
|
2018
Q2 | $2.98M | Sell |
86,520
-1,865
| -2% | -$63.7K | 0.54% | 75 |
|
|
2018
Q1 | $2.98M | Buy |
88,385
+36,732
| +71% | +$1.26M | 0.55% | 76 |
|
|
2017
Q4 | $1.77M | Sell |
51,653
-52
| -0.1% | -$1.77K | 0.31% | 82 |
|
|
2017
Q3 | $1.75M | Hold |
51,705
| – | – | 0.33% | 83 |
|
|
2017
Q2 | $1.65M | Sell |
51,705
-1,054
| -2% | -$33.2K | 0.31% | 85 |
|
|
2017
Q1 | $1.71M | Buy |
52,759
+764
| +1% | +$24.1K | 0.33% | 84 |
|
|
2016
Q4 | $1.6M | Buy |
51,995
+42,411
| +443% | +$1.29M | 0.31% | 85 |
|
|
2016
Q3 | $308K | Hold |
9,584
| – | – | 0.06% | 147 |
|
|
2016
Q2 | $320K | Buy |
9,584
+153
| +2% | +$4.88K | 0.07% | 143 |
|
|
2016
Q1 | $265K | Sell |
9,431
-68
| -0.7% | -$1.94K | 0.06% | 150 |
|
|
2015
Q4 | $291K | Buy |
9,499
+742
| +8% | +$23.3K | 0.06% | 146 |
|
|
2015
Q3 | $261K | Sell |
8,757
-949
| -10% | -$30.4K | 0.06% | 150 |
|
|
2015
Q2 | $309K | Buy |
9,706
+621
| +7% | +$20.2K | 0.06% | 139 |
|
|
2015
Q1 | $300K | Sell |
9,085
-527
| -5% | -$16.8K | 0.06% | 143 |
|
|
2014
Q4 | $284K | Sell |
9,612
-125
| -1% | -$3.58K | 0.05% | 146 |
|
|
2014
Q3 | $277K | Sell |
9,737
-1,483
| -13% | -$41.6K | 0.05% | 150 |
|
|
2014
Q2 | $316K | Hold |
11,220
| – | – | 0.06% | 137 |
|
|
2014
Q1 | $342K | Buy |
11,220
+200
| +2% | +$5.96K | 0.07% | 136 |
|
|
2013
Q4 | $320K | Buy |
11,020
+2,521
| +30% | +$73.4K | 0.06% | 139 |
|
|
2013
Q3 | $232K | Sell |
8,499
-527
| -6% | -$14.3K | 0.05% | 154 |
|
|
2013
Q2 | $240K | Buy |
+9,026
| New | +$249K | 0.06% | 143 |
|
Other funds holding PFE
Thompson Investment Management's PFE Position: Q2 2026 in Review
Thompson Investment Management increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $134K and bringing the position to 469,287 shares worth $11.3M. The position accounts for 1.3% of the portfolio, ranked #22.
Thompson Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Thompson Investment Management held 469,287 shares of Pfizer worth $11.3M as of Q2 2026.
- Thompson Investment Management bought 5,116 Pfizer shares in Q2 2026, an estimated $134K.
- Pfizer made up 1.3% of Thompson Investment Management's portfolio in Q2 2026, its #22 holding.
- Thompson Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Thompson Investment Management's Pfizer position peaked at $13M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.